Evidence map›Paper›PMID 35834948›Full record

ReviewCurrent opinion in structural biology2022

Microbial pathways to subvert host immunity generate citrullinated neoantigens targeted in rheumatoid arthritis.

Eduardo Gómez-Bañuelos, Maximilian F Konig, Felipe Andrade

Open access · greenAbstract readReview
In one paragraph

Review in Current opinion in structural biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
  3. Microbial threads in the tapestry of rheumatoid arthritis.The Journal of clinical investigation · 2025
    Review
  4. Review
  5. Autoimmunity: the neoantigen hypothesis.Frontiers in immunology · 2024
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Eduardo Gómez-BañuelosDivision of Rheumatology, The Johns Hopkins University School of Medicine, Baltimore, MD, USA. Electronic address: https://twitter.com/@Eduardo95668787.
Maximilian F KonigDivision of Rheumatology, The Johns Hopkins University School of Medicine, Baltimore, MD, USA. Electronic address: https://twitter.com/@MaxKonigMD.
Felipe AndradeDivision of Rheumatology, The Johns Hopkins University School of Medicine, Baltimore, MD, USA. Electronic address: andrade@jhmi.edu.
Johns Hopkins University · US

Funding

The role of complement citrullination in RA pathogenesisR01AR069569 · NIAMS · JOHNS HOPKINS UNIVERSITY · PI ANDRADE, FELIPE · 2016 to 2020
$1.8M
Peptidylarginine deiminase type 6 in rheumatoid arthritis pathogenesisR21AR079891 · NIAMS · JOHNS HOPKINS UNIVERSITY · PI ANDRADE, FELIPE · 2021 to 2021
$396k
NIAMS NIH HHS R01 AR069569NIAMS NIH HHS R21 AR079891
6 · The paper itself

Abstract

The specific association between antibodies to citrullinated proteins and rheumatoid arthritis (RA) has centered interest on understanding why citrullinated proteins become immunogenic in this disease, which is believed to inform the origins of autoimmunity in RA. Since citrullination is a physiologic post-translational modification (PTM), one theory is that conditions promoting abnormal citrullination are initiators of self-reactive immune responses to citrullinated proteins in RA. Foremost candidates that dysregulate the normal balance of citrullination are microbial agents, which can exploit citrullination as an effector mechanism to subvert host antimicrobial activities and maximize their progeny. Here, we will use the host-pathogen interface as a unifying model to link microbe-induced citrullination and the loss of immunological tolerance to citrullinated antigens in RA.

Indexed as

Arthritis, RheumatoidCitrullineAutoimmunityCitrullinationHumansProtein Processing, Post-TranslationalCitrulline

Identifiers

PMID35834948
PMCPMC9668488
OpenAlexW4285033507

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.